The deal represents a success for the development agency, which has sometimes struggled to exit investment projects on favourable terms.
Details of one of last year's key biotech deals have been closely guarded for a year but the Sunday Herald has learned that February's sale of Midlothian-based diagnostics firm, Lab901, to Californian life sciences giant Agilent Technologies, saw Scottish Enterprise (SE) make a return of more than twice its £2.4m investment. But some of the business angels who launched the company by injecting £450,000 in 2002 under Edinburgh-based syndicate Archangel Informal Investments actually made a 20% loss.
